Introduction
Development of efficient gene therapeutics would depend largely on the availability of vectors that allow an efficient and selective delivery of therapeutic genes to target cells with minimal toxicity. [1] [2] [3] Because potentially a large variety of very different genes need to be delivered and many types of organs and tissues that cells need to be targeted for the therapy of different diseases, an immensely broad range of gene delivery technologies is foreseen to be necessary to cater for all the conceivable applications and treatments. [4] [5] [6] Instability of naked DNA, possible adverse effects of viral vectors, and potential immune responses associated with viral methods of DNA delivery, have warranted the development of non-viral, synthetic carriers as alternative approaches for gene delivery. 5, 7, 8 Although non-viral vectors are comparatively safer than viral vectors, can be produced relatively easily in large quantities, and could have higher DNA-carrying capacity, they are generally less efficient in delivering DNA and initiating gene expression as compared to viral vectors, particularly when used in vivo. 3, 7 Nanotechnology is a multi-disciplinary field that involves the design and engineering of nanomaterials that are o500 nm in size. Recently, there have been substantial advances in the application of nanomaterials, especially bioceramics, for cancer diagnostics and as carriers for delivering small therapeutics molecules. [9] [10] [11] [12] There are many critical features of these bioceramics nanoparticles that enable them to function as ideal DNA carriers. 13, 14 One could easily modify the particle size, stability, and loading capacity of these particles by customizing the structures and physicochemical properties to ensure their effectiveness and safety for clinical applications.
In this study, we have explored the potential of several unique bioceramic nanoparticles with diverse physical characteristics to act as durable, safe and efficient synthetic gene delivery vehicles.
Results

Physical properties of the synthetic nanosized bioceramic particles
The ability of nanosized bioceramic particles including silica (SiO 2 ), hydroxyapatite (HA), and zirconia (ZrO 2 ) nanoparticles to act as gene delivery vehicles was studied.
SiO 2 nanoparticles are produced from radio frequency (RF) plasma spraying. 15 The spray process involves the inductive coupling of an oscillating electrical energy to form a RF plasma through which precursors are delivered axially through a water-cooled probe into a low-intensity plasma operating at 35 kW and 3 MHz to produce ultrafine nanoparticles, or composites. Specifically, for the synthesis of SiO 2 , gaseous SiC l4 and O 2 are used. Zeta potential determination revealed the SiO 2 nanoparticles to have had an extremely negative surface charge of À43.4 mV (z ¼ À43.4 mV) at pH 7.0. They are approximately 30 nm in size and are almost spherical in shape (Figure 1a (i 16 HA particles are spheroids, approximately 50 nm in size, and z ¼ +0.12 mV (Figure 1a (ii)). They are stable at pH 7.0 and dissolve at pHo5.5. ZrO 2 nanoparticles are commercially available (Alfa Asear, Ward Hill, MA, USA). These particles are pleomorphic, approximately 80 nm in size (Figure 1a (iii)), and z ¼ +64.1 mV. ZrO 2 nanoparticles are stable at pH 7.0 and under acidic conditions.
Modulation of the surface charge of the bioceramic nanoparticles to optimize DNA binding and transgene expression
Probably due to the extended size of hydrated DNA and its overall negative charge density, it is difficult for naked DNA to cross the nuclear membrane pore into the nucleus where transgene expression could take place. 17, 18 To facilitate the formation of nanoparticles-DNA complex through electrostatic attraction, we have employed positively charged amino acids, including lysine (Lys), histidine (His), arginine (Arg) and the cationic polymeric amino acids poly-L-lysine (PLL), polyarginine, polyhistidine and protamine sulfate (PS) to coat the surface of these nano-particles to modulate the overall surface charge of these nanoparticles so they could interact with DNA to produce nearly charge-neutral DNA-nanoparticle complexes. When 2% of different surface-modulating agents was employed in conjunction with 3 mg DNA, it was found that PS gave the highest transgene expression with both SiO 2 and HA nanoparticles ( Figure1b (i and ii) ). Moreover, in the presence of PS, the zeta potentials of both SiO 2 -DNA and HA-DNA nanoplexes transited from negative to positive charge ( Figure1c (i and ii) ). On the other hand, PS-ZrO 2 -DNA nanoplexes could not mediate good transgene expression for all the three cell lines tested (Figure 1b (iii) ). Both unmodified and surfacecoated ZrO 2 nanoparticles remained strong positively charged either in the absence or in the presence of DNA (Figure 1c (iii) ).
Optimization of the PS-SiO 2 -DNA nanoplexes gene delivery system
As PS-modified SiO 2 (PS-SiO 2 ) could enable highest transgene expression (Figure 1b) , we therefore focused our subsequent studies on optimizing the ability of PS-SiO 2 -DNA nanoplexes to act as a vehicle for gene delivery.
First, for 10 mg of DNA, by varying the amount of PS to determine the optimal amount of PS to modify the surface of 0.5 mg SiO 2 nanoparticles to enable the maximum binding of DNA, it was determined that DNA binding would be saturated at 5% PS (Figure 2a) . Moreover, at 5% PS, the maximum amount of DNA that 0.5 mg SiO 2 nanoparticles could bind was 10 mg (Figure  2b ). Therefore, for subsequent experiments, we routinely used 5% PS to coat the SiO 2 nanoparticles and 10 mg of plasmid DNA was used per 0.5 mg SiO 2 nanoparticles. Under these conditions, the PS-SiO 2 -DNA nanoplexes could mediate good transgene expression in human HepG2 cells, especially in the presence of 50% serum ( Figure 2c ). In comparison, Calphos PS-HA-DNA, and PS-ZrO 2 -DNA nanoplexes gave only marginal level of luciferase gene expression both in the absence and the presence of 50% serum ( Figure 2c ).
PS-SiO 2 -DNA nanoplexes targeted transgene expression to the spleen of recipient mice
After optimizing the PS-SiO 2 nanoparticles to mediate DNA gene transfer in vitro, the ability of the PS-SiO 2 nanoparticles to enable transgene expression in vivo was Figure 3a ). Only marginal increase in luciferase expression could be detected in the liver and the kidneys (Figure 3a) . When a larger dose of 8 mg of PS-SiO 2 nanoparticles containing 160 mg luciferase DNA was administered, significant level of luciferase expression could be detected in both the spleen and the liver of the recipient mice (Figure 3a) . It is likely that at low concentrations (4 and 5 mg) of the PS-SiO 2 nanoplexes, transgene expression was targeted at the spleen of the recipient. At higher concentrations of the nanoplexes, transgene expression in the liver could be detected, probably resulting from the nonspecific uptake of the nanoplexes by the liver. However, no noticeable toxicity could be detected even with 8 mg of PS-SiO 2 nanoparticles. For a time-course study, mice were injected with 4 mg of PS-SiO 2 nanoparticles and 80 mg luciferase DNA. It was determined that 6 h following the injection of the nanoplexes, significant luciferase expression could be detected in the spleen of the recipient mice (Figure 3b) . However, the luciferase expression was transient. The expression peaked at 12 h following injection and then gradually decreased (Figure 3b) .
The apparent targeting of exogenous transgene expression at the spleen was further studied by confocal microscopy. When 80 mg of tetramethyl- 
rhodamine-labeled-pNGVL-Luc DNA was mixed with 4 mg of PS-SiO 2 nanoparticles and i.p. injected into BALB/c mice, the highest level of rhodamine-labeled DNA nanoplexes could be detected only in the spleens of the recipient mice and it appeared that the expression concentrated over the marginal zone of the mouse spleen (Figure 3c) . No nanoplexes could be detected in the liver and kidneys of the recipient (Figure 3c) . Therefore, PSSiO 2 nanoparticles could act as an effective gene delivery vehicle with targeting specificity to the spleen.
PS-SiO 2 nanoparticles could mediate functional antitumor immune responses
As the spleen is one of the most important lymphoid organs involved in the initiation of immune response 19 and the PS-SiO 2 nanoparticles could target transgene expression to the spleen, hence, we examined the potential of the PS-SiO 2 nanoparticles to enhance immune responses. Previously, we have generated the DNA-construct, pNGVL-hFLex-MUC-1, encoding the extracellular domain of human Flt-3 ligand (Flt-3L) ligated in frame to the tumor epitope muc-1 to express a fusion protein. 20, 21 Conceivably, Flt-3L induced DC expansion in vivo, which will then be loaded with the secreted muc-1 component to generate an effective antimuc-1 immune response. 20, 21 To study the ability of the PS-SiO 2 nanoparticles to mediate expression of the pNGVL-hFLex-MUC-1 gene, mice were injected with 4 mg PS-SiO 2 nanoparticles carrying 80 mg of the pNGVL-hFLex-MUC-1 DNA i.p. It was observed that serum Flt-3L expression peaked 1 day after the injection of PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes at 1600-2300 pg/ml (Figure 4a ) and then decreased progressively to basal level by day 7 (Figure 4a (i)) . Furthermore, the level of anti-muc-1 antibody detected following immunization with PS-SiO2-pNGVL-hFLexMUC-1 nanoplex, although detectable, was at a much reduced level when compared to that obtained following immunization with the muc-1 peptide (Figure 4a (ii) ).
To induce muc-1-specific immune responses, C57BL/6 mice were primed weekly with 4 mg of PS-SiO 2 -pNGVL- (Figure 4b  (i) ). The level of IFN-g produced in mice immunized with PS-SiO 2 -pNGVL-hFLex or PS-SiO 2 -pNGVL-hFLex-MUC-1 DNA was elevated to over 5000 pg/ml. On further stimulation with muc-1 in vitro, a slight but noticeable increase in IFN-g expression could only be specifically observed with splenocytes from mice primed earlier with PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes (Figure 4b (i)). IL-2 expression was, however, comparable in all the splenocytes cultures and no further specific IL-2 response could be detected in the presence of muc-1 (Figure 4b (ii) ). Most importantly, the repeated immunizations of mice with PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes generated potent anti-muc-1 tumor responses. Figure 4c showed the retardation of tumor growth in the groups of mice inoculated with either PS-SiO 2 -pNGVL-hFLex or PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes when compared to control groups of mice immunized with PS-SiO 2 -pNGVL nanoplexes or PS-SiO 2 nanoparticles alone (data not shown). Although the rate of tumor growth was moderately reduced in the group of mice immunized with PS-SiO 2 -pNGVL-hFLex nanoplexes, growth of the RMA-MUC-1 tumor for mice immunized with the PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes was significantly retarded (Figure 4c ).
Discussion
Gene delivery offers the potentials to (a) replace missing or defective genes; (b) deliver genes that catalyze the destruction of cancer cells; (c) cause cancer cells to revert back to normal tissue; (d) deliver viral or bacterial genes as a form of vaccination; (e) deliver genes that promote the growth of new tissue or stimulate; and (f) regenerate damaged tissue. 22 Because potentially a large number of different genes need to be transported, and different types of organs and tissues whose cells need to be targeted for genetic therapy of different diseases, a broad range of gene delivery technologies is necessary for effective treatments. The ability of bioceramics nanoparticles to act as potential non-viral gene delivery vehicles was studied. The physical properties of nanoparticles, including their morphology, size, charge density and colloidal stability, are important parameters to determine the overall efficacy of nanoparticles to act as potential non-viral gene delivery vehicles. In this report, three different types of bioceramics nanoparticles with different shapes, sizes and surface charges were compared. The sizes of the three nanoparticles studied were all below 150 nm: the smallest being SiO 2 of 30 nm, then HA of 50 nm, and ZrO 2 of 80 nm, and would therefore enable efficient endocytosis.
Polycations promote the condensation of plasmid DNA into compact molecular complexes to enhance efficient cell uptake and protect the DNA from degradation by intracellular nucleases. 1, 23, 24 In addition, the net positive charge resulting from the presence of amine groups provides buffering ability that allows safe escape from endosome/lysosome. 17, 18 In this study, we have employed PS, a FDA approved USP compound for clinical use in counteracting the effects of heparininduced anticoagulation after cardiac and vascular surgery, 25, 26 to enhance the transfection efficacies of the SiO 2 , HA and ZrO 2 nanoparticles. It was observed that PS was able to modulate effectively the surface charges of the neutrally charged HA and negatively charged SiO 2 nanoparticles into the positive range, thus allowing the binding of the net positively charged nanoparticles to the overall negatively charged DNA molecules through strong electrostatic interactions (Figure 1c (i) and (ii) ). Many non-viral vectors suffer the limitation that transgene expression is rendered ineffective in the presence of 50% serum. The PS-SiO 2 -DNA nanoplexes are stable in 50% serum and high transgene expression could be detected in human HepG2 cells for a period of more than 72 h (Figure 2c) . The enhanced transgene expression in the presence of 50% serum was only with PS-SiO 2 -DNA nanoplexes and not the other nanoparticles studied (Figure 2c ). This suggested that the high serum concentration could function to stabilize further the PS-SiO 2 -DNA nanoplexes, and provided an added advantage to employ the SiO 2 nanoparticles for in vivo gene delivery.
Intraperitoneal inoculation of PS-SiO 2 -DNA nanoplexes in mice resulting in significant and sustainable level of transgene expression specifically in the spleen (Figure 3 ) suggests its potential applications for cancer immunotherapy. The spleen has been documented to be one of the most important lymphoid organs involved in the initiation of immune responses. 19, 27 The involvement of its marginal zone through specific macrophage and marginal-zone B cells population can efficiently mount both innate and adaptive immune. PS-SiO 2 -DNA nanoplexes induced potent tumor-specific immune responses following priming mice with PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes. Flt-3L has the capacity to induce expansion of functional DC whereas mucin acts as tumor-specific epitopes. 20, 21 In contrary to our previously observation, 20, 21 we did not detect the expansion of DC within the spleens of recipient mice immunized with PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes (data not shown) although we could detect high level of serum Flt-3L (Figure 4a) . However, the presence of high IFN-g expression in the culture supernatants of the splenocytes from PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes-primed mice (Figure 4b (i) ) and the subsequent protection against tumor growth when challenged with muc-1 + tumor cells (Figure 4c ) strongly suggested the presence of specific anti-muc-1 tumor immune responses. Recently, we have reported that intramuscular immunization of mice with pNGVL-hFLex-MUC-1 did not require DC expansion to generate a potent CTL response and there was no significant antibody response in these mice. 21 We have suggested that Flt-3L possibly acted as an adjuvant to enable MUC-1 processing and presentation by APC to generate an efficient immune response, and that the route of immunization is critical in determining the type of immune response generated. 28, 29 Our observations following immunization with PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes were consistent with the presence of NKDC. This preliminary observation is currently being investigated.
In summary, we have demonstrated that the PS-SiO 2 -DNA nanoplexes could specifically target transgene expression in the spleen of recipient mice and promote specific immunologically mediated tumor protection. Although the exact cellular mechanism involved in the tumor rejection is not clear, our present study demonstrates the applicability of the PS-SiO 2 -DNA nanoplexes for immuno-therapeutic strategies. 
Materials and methods
Mice
Female BALB/c mice were purchased from the Animal Laboratory Unit of the National University of Singapore. Female C57BL/6 mice were purchased from the Animal Resources Centre (Perth, Western Australia). Mice were used at 8-12 weeks of age. All mice were housed in pathogen-free (SPF) environment in the animal facility of the National Cancer Center (Singapore), according to guidelines set by the National Advisory Committee for Laboratory Animal Research.
Nanoparticles
SiO 2 nanoparticles are produced from RF plasma spraying. The spray process involves the inductive coupling of an oscillating electrical energy to form a RF plasma through which precursors are delivered axially through a water-cooled probe into a low-intensity plasma operating at 35 kW and 3 MHz to produce ultrafine nanoparticles or composites. 15 Specifically, for the synthesis of SiO 2 , gaseous SiC l4 and O 2 are used. Stoichiometric HA with calcium/phosphate (Ca/P) ratio of 1.67 was synthesized by the reaction of 0.28 M o-phosphoric acid (Merck & Co Inc., NJ, USA) with 0.5 M calcium hydroxide (Merck & Co Inc.) under steadystate condition as described previously. 16 SiO 2 nanoparticles were synthesized using RF spray process at plate power of 50 kW. ZrO 2 nanoparticles suspension was purchased from Alfa Aesar (Ward Hill, MA, USA).
Electron micrographs of the nanoparticles were captured using the JSM-6700F FEG SEM (JEOL) with the scanning electron mode at 5 KV and the scanning transmission electron mode at 20 kV. The surface charge of the nanoparticles and nanoparticles-DNA complexes were measured using the ZetaSizer 3000 HS (Malvern Instruments Ltd, Worcestshire, UK). The zeta potential was determined by measuring three 10-cycle runs at 1.5 mA with count rates between 50 and 3000 Kcps.
Surface polycationic modification of nanoparticles
Amino acids including L-lysine (Lys), L-histidine (His), L-arginine (Arg) and cationic polymeric amino acids including poly-L-lysine (PLL), polyarginine, polyhistidine and PS were used as surface-modifying agents (Sigma-Aldrich). The nanoparticles were incubated overnight at 41C for adsorption to take place.
Surface-modified nanoparticles were washed and suspended in 500 ml of 10 mM Tris pH 7.0. Plasmid DNA was added gradually to the nanoparticles suspension and vortexed. The mixture was incubated at RT for 1 h in 371C water bath to allow the complete formation of nanoplexes. Both the pNGVL3-hFLex and pNGVLhFLex-MUC-1 constructs have been described previously. 20, 21 For confocal microscopy studies, luciferase plasmid DNA was labeled, according to manufacturer's instructions, with the Label IT TM-rhodmaine DNA Nucleic Acid labeling kit (Mirus, Madison, WI, USA). About 80 mg of tetramethyl-rhodamine-labeled-pNGVL-Luc DNA was mixed with 4 mg PS-SiO 2 and injected i.p. into BALB/c mice. Spleen, liver and kidney sections were harvested 3 h after TM-rhodamine-labeled DNA infusion. The tissues were kept in 4% paraformaldehyde with 10% sucrose in phosphate-buffered saline (PBS) for 24 h at 41C. Cryosections (10 mm) were performed on the fixed tissues at À121C. A 1% bovine serum albumin (BSA) in PBS was used as the blocking solution to reduce background staining. After further washing with PBS, filamentous actin were stained with 1 mg/ml of fluorescein isothiocynate (FITC)-phalloidin (Sigma-Aldrich) and cell nuclei were stained with Hoescht 33342 (1 mg/ml). Images were captured using LSM 510 Meta confocal microscope (Carl Zeiss Microscopy, Gö ttingen, Germany).
Determination of serum Flt-3L
Serum Flt-3L was assayed using Quantikine's human Flt-3 Ligand Immunoassay kit (R&D Systems, Minneapolis, MN, USA) as described previously. 20 
Quantification of IFN-g and IL-2 production
White blood cells isolated from immunized mice were cultured at 5 Â 10 5 cells/well in 96-wells round-bottom plate (Nalge Nunc International, Rochester, NY, USA), in the presence and the absence of 10 mg/ml of muc-1 peptide at 371C. Culture supernatant was collected on days 2 and 3. IFN-g was determined using Endogen's mouse IFN-g ELISA kit (Pierce Biotechnology Inc., Rockford, IL, USA), whereas IL-2 was determined with Endogen's mouse IL-2 ELISA kit (Pierce Biotechnology Inc.).
Tumor protection assay
Mice were immunized thrice with PS-SiO 2 -pNGVL nanoplexes, PS-SiO 2 -pNGVL-hFLex, or PS-SiO 2 -pNGVL-hFLex-MUC-1 nanoplexes. On day 7 after the third inoculation, each of the immunized mice was challenged subcutaneously with 5 Â 10 5 RMA-MUC-1 tumor cells at the right hind legs. Each group contained SiO 2 nanoparticles for targeted gene delivery K Tan et al eight mice. The development of tumor was monitored daily and the size of tumor was measured as a product of two perpendicular diameters.
